Faculty Opinions recommendation of Tanezumab reduces osteoarthritic hip pain: results of a randomized, double-blind, placebo-controlled phase III trial.
Keyword(s):
2003 ◽
Vol 95
(10)
◽
pp. 762-763
Keyword(s):
2018 ◽
Vol 25
(8)
◽
pp. 2424-2432
◽
Keyword(s):
Keyword(s):